Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361279661> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4361279661 abstract "In 2020, dupilumab became the first monoclonal antibody therapy to be approved by Health Canada for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). The primary aim of this study was to characterize the outcomes in an initial cohort of patients with CRSwNP who have undergone dupilumab therapy.A retrospective study was conducted of patients with CRSwNP who were treated with dupilumab. Demographic information, comorbidities, number of previous surgeries, and insurance information were collected. The primary outcome were changes in the sinonasal outcome test (SNOT-22) scores from baseline to timepoints after receiving dupilumab.Forty-eight patients were considered for dupilumab therapy, and 27 (56%) received coverage or were able to fund the medication independently. Patients waited an average of 3.6 months to obtain access to the medication. The mean age of the patients was 43. Forty-one percent (11/27) of patients had aspirin exacerbated respiratory disease, and 96% (26/27) had a diagnosis of asthma. The mean length of time on dupilumab was 12.1 months. The baseline SNOT-22 score was 60.6. The mean decrease at 1 month, 3 months, 6 months, and 12 months after starting dupilumab was 8.8, 26.5, 42.8, and 33.8, respectively. There were no serious adverse events.Patients treated with dupilumab in a Canadian tertiary care rhinology clinic demonstrated substantial clinical improvement as measured by disease-specific sinonasal outcomes. Further studies are needed to determine the longer-term effectiveness and adverse event profile of this novel therapy." @default.
- W4361279661 created "2023-03-31" @default.
- W4361279661 creator A5000331309 @default.
- W4361279661 creator A5009875359 @default.
- W4361279661 creator A5089512588 @default.
- W4361279661 date "2023-03-30" @default.
- W4361279661 modified "2023-09-25" @default.
- W4361279661 title "Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice" @default.
- W4361279661 cites W1606887512 @default.
- W4361279661 cites W1863336353 @default.
- W4361279661 cites W2004627112 @default.
- W4361279661 cites W2007487522 @default.
- W4361279661 cites W2013478501 @default.
- W4361279661 cites W2030674948 @default.
- W4361279661 cites W2149116105 @default.
- W4361279661 cites W2166931169 @default.
- W4361279661 cites W2170165234 @default.
- W4361279661 cites W2221351268 @default.
- W4361279661 cites W2289316671 @default.
- W4361279661 cites W2321512095 @default.
- W4361279661 cites W2594220482 @default.
- W4361279661 cites W2906456473 @default.
- W4361279661 cites W2973437633 @default.
- W4361279661 cites W3014934509 @default.
- W4361279661 cites W3035976855 @default.
- W4361279661 cites W3107155720 @default.
- W4361279661 cites W3132168886 @default.
- W4361279661 cites W3139127912 @default.
- W4361279661 cites W3155240132 @default.
- W4361279661 cites W3202033471 @default.
- W4361279661 cites W3215951222 @default.
- W4361279661 cites W4200491428 @default.
- W4361279661 cites W4224440703 @default.
- W4361279661 cites W4229451011 @default.
- W4361279661 doi "https://doi.org/10.1186/s13223-023-00782-7" @default.
- W4361279661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36998065" @default.
- W4361279661 hasPublicationYear "2023" @default.
- W4361279661 type Work @default.
- W4361279661 citedByCount "2" @default.
- W4361279661 countsByYear W43612796612023 @default.
- W4361279661 crossrefType "journal-article" @default.
- W4361279661 hasAuthorship W4361279661A5000331309 @default.
- W4361279661 hasAuthorship W4361279661A5009875359 @default.
- W4361279661 hasAuthorship W4361279661A5089512588 @default.
- W4361279661 hasBestOaLocation W43612796611 @default.
- W4361279661 hasConcept C108516343 @default.
- W4361279661 hasConcept C126322002 @default.
- W4361279661 hasConcept C141071460 @default.
- W4361279661 hasConcept C167135981 @default.
- W4361279661 hasConcept C197934379 @default.
- W4361279661 hasConcept C2776042228 @default.
- W4361279661 hasConcept C2779824493 @default.
- W4361279661 hasConcept C2781390199 @default.
- W4361279661 hasConcept C501107679 @default.
- W4361279661 hasConcept C71924100 @default.
- W4361279661 hasConcept C72563966 @default.
- W4361279661 hasConceptScore W4361279661C108516343 @default.
- W4361279661 hasConceptScore W4361279661C126322002 @default.
- W4361279661 hasConceptScore W4361279661C141071460 @default.
- W4361279661 hasConceptScore W4361279661C167135981 @default.
- W4361279661 hasConceptScore W4361279661C197934379 @default.
- W4361279661 hasConceptScore W4361279661C2776042228 @default.
- W4361279661 hasConceptScore W4361279661C2779824493 @default.
- W4361279661 hasConceptScore W4361279661C2781390199 @default.
- W4361279661 hasConceptScore W4361279661C501107679 @default.
- W4361279661 hasConceptScore W4361279661C71924100 @default.
- W4361279661 hasConceptScore W4361279661C72563966 @default.
- W4361279661 hasIssue "1" @default.
- W4361279661 hasLocation W43612796611 @default.
- W4361279661 hasLocation W43612796612 @default.
- W4361279661 hasLocation W43612796613 @default.
- W4361279661 hasOpenAccess W4361279661 @default.
- W4361279661 hasPrimaryLocation W43612796611 @default.
- W4361279661 hasRelatedWork W3043952823 @default.
- W4361279661 hasRelatedWork W3097905741 @default.
- W4361279661 hasRelatedWork W3213277373 @default.
- W4361279661 hasRelatedWork W4200102219 @default.
- W4361279661 hasRelatedWork W4200464985 @default.
- W4361279661 hasRelatedWork W4210803306 @default.
- W4361279661 hasRelatedWork W4224440703 @default.
- W4361279661 hasRelatedWork W4293569730 @default.
- W4361279661 hasRelatedWork W4361279661 @default.
- W4361279661 hasRelatedWork W4366205211 @default.
- W4361279661 hasVolume "19" @default.
- W4361279661 isParatext "false" @default.
- W4361279661 isRetracted "false" @default.
- W4361279661 workType "article" @default.